Concepedia

Narittira Ornnork

NO

Statistics

Publications

4

Citations

59

H-Index

4

Active since

2020

Affiliations

Chulabhorn Research Institute(Current)

Chulabhorn Graduate Institute

Ministry of Education

Narittira Ornnork is an author at Chulabhorn Research Institute specializing in medicinal chemistry, enzyme inhibition, and pharmacy.

Publications per year

2020–2023

4

Publications

4

Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure–activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study

Rungroj Saruengkhanphasit, Chutikarn Butkinaree, Narittira Ornnork et al. · Bioorganic Chemistry · 2021 · 21 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening

Narittira Ornnork, Duangnapa Kiriwan, Kriengsak Lirdprapamongkol et al. · Journal of Molecular Graphics and Modelling · 2020 · 17 citations

Pharmacy, Medicinal Chemistry, Oncology +15

JAK2/STAT3‑mediated dose‑dependent cytostatic and cytotoxic effects of sesquiterpene lactones from <i>Gymnanthemum extensum</i> on A549 human lung carcinoma cells

Siriporn Keeratichamroen, Kriengsak Lirdprapamongkol, Sanit Thongnest et al. · Oncology Reports · 2021 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

p‑STAT3 influences doxorubicin and etoposide resistance of A549 cells grown in an in vitro 3D culture model

Siriporn Keeratichamroen, Thiwaree Sornprachum, Lukana Ngiwsara et al. · Oncology Reports · 2023 · 10 citations · Full text

Medicine, Cell Biology, Oncology +17

1–4 of 4